Sales and Marketing
Scotland’s life sciences sector on track to break $8 billion by 2025
February 25, 2020 Manufacturing and Production, Sales and Marketing Scotland, UK, life sciences, pharma
FDA greenlights first oral, daily, non-statin therapy for lowering LDL-Cholesterol
February 25, 2020 Manufacturing and Production, Sales and Marketing Esperion, FDA, Nexletol, pharma
2020 Veeva Unified Clinical Operations Survey
February 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, survey, veeva
FDA approves first adjuvanted quadrivalent flu vaccine in over-65s
February 24, 2020 Sales and Marketing FDA, flu, influenza, pharma, seqirus
Clover Biopharmaceuticals partners up with GSK to accelerate coronavirus vaccine development
February 24, 2020 Sales and Marketing China, Clover Biopharmaceuticals, GSK, coronavirus, pharma
Eli Lilly’s Trulicity approved in US to reduce cardiovascular events in type 2 diabetes patients
February 24, 2020 Sales and Marketing Eli Lilly, Trulicity, cardiovascular disease, pharma
Lundbeck’s Vyepti secures US approval for migraine prevention
February 24, 2020 Sales and Marketing FDA, Lundbeck, Vyepti, migraine, pharma
FDA approval for Baudax Bio’s non-opioid painkiller Anjeso
February 24, 2020 Sales and Marketing Anjeso, FDA, opioids, pharma
Merck KGaA to flog Allergopharma business to Dermapharm
February 21, 2020 Medical Communications, Sales and Marketing Allergopharma, Dermapharm, Merck KGaA, pharma
Top Ten most popular articles on Pharmafile.com this week
February 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug market, Europe, coronavirus, opioid crisis, opioids
New Keytruda dosing schedule rejected in six cancers by the FDA
February 20, 2020 Sales and Marketing Cancer, FDA, MSD, keytruda, pharma
FDA approved over 1,000 generic drugs in 2019
February 20, 2020 Research and Development, Sales and Marketing FDA, generic drugs, pharma
Europe approves first treatment for transthyretin amyloidosis in cardiomyopathy patients: Pfizer’s Vyndaqel
February 19, 2020 Research and Development, Sales and Marketing Europe, Pfizer, Vyndaqel, pharma, transthyretin amyloidosis
Women who take statins could be less likely to develop ovarian cancer, study finds
February 19, 2020 Research and Development, Sales and Marketing Cancer, Cancer Research UK, cholesterol, ovarian cancer, statins
Novartis’ Beovu approved in Europe after outclassing Eylea in wet age-related macular degeneration
February 18, 2020 Manufacturing and Production, Sales and Marketing Beovu, Eylea, Novartis, Regeneron, macular degeneration, pharma
Latest content
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
